Palbociclib is an oral chemotherapy used to treat advanced breast cancer. This drug is used as part of a combination therapy. That means it is taken with other drugs. Palbociclib is generally taken in combination with letrozole
Ibrance (Palbociclip 125mg) ) is a product of Pfizer and is known as IBRANCE in other parts of the world
The drug was approved for use in the European Union in November 2016 as a treatment for hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer
Palbace comes in capsule form in 125 mg dose. 1 pack has 21 capsules.
In order to legally purchase this medicine you’ll require a prescription from your Registered Medical Practitioner.
The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
Remember, keep this and all other medicines out of the reach of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed.
The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.